≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

ILD medications: nintedanib

Endpoint Browser

ILD_NINTENDANIB

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Medicine purchases: ATC — L01XE31

1 out of 7 registries used, show all original rules.

194

4. Check minimum number of events

Min. number of events 3
194

5. Include endpoints

None

194

6. Filter based on genotype QC (FinnGen only)

194

Control definitions (FinnGen only)

Control exclude
ILD_MEDICATIONS

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 194 58 136
Unadjusted period prevalence (%) 0.05 0.02 0.06
Median age at first event (years) 70.52 71.20 70.22

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
183
Matched controls
1831
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L01XE31
ATC
[U] nintedanib; oral
+∞
264.8
183
*
284
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
264.8
183
*
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
+∞
251.2
183
8
356
Kela drug reimbursment
Nintedanib and pirfenidone
+∞
182.0
143
*
L01EX09
ATC
nintedanib; oral
+∞
116.5
99
*
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
186.5
95.2
93
10
L04AX05
ATC
pirfenidone; oral
+∞
86.5
76
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
58.8
83.6
98
35
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
54.1
62.0
73
22
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
57.8
57.7
67
18
XG410
NOMESCO Finland
Flow-volume spirometry
35.9
47.3
61
25
H02AB06
ATC
prednisolone; systemic
9.2
41.7
129
376
UGC12
NOMESCO Finland
Flexible bronchoscopy
14.2
41.4
77
89
GD1AA
NOMESCO Finland
Thorax X-ray examination
9.6
37.9
153
633
TGC00
NOMESCO Finland
Bronchial lavation
27.2
31.9
44
21
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
14.2
29.8
53
51
R03AC02
ATC
salbutamol; inhalant
6.1
28.2
134
564
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
24.6
25.6
36
18
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
7.5
25.1
67
131
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
18.9
24.6
38
25
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
137.2
23.2
24
*
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
124.3
21.1
22
*
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
82.6
20.2
22
*
GD1AD
NOMESCO Finland
Thorax CT examination
12.2
19.5
36
36
J96.1
ICD-10 Finland
Chronic respiratory failure
28.7
18.8
25
10
R06.0
ICD-10 Finland
Dyspnoea
4.2
16.9
80
283
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
33.6
16.5
21
7
J18.9
ICD-10 Finland
Pneumonia, unspecified
4.2
15.8
75
262
WX721
NOMESCO Finland
Oxygen concentrator therapy
162.4
14.7
15
*
R03BA08
ATC
ciclesonide; inhalant
8.2
14.5
33
48
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
6.6
14.2
38
70
R05
ICD-10 Finland
Cough
4.1
13.9
63
207
L04AA06
ATC
mycophenolic acid; systemic
+∞
13.7
13
*
Z51.5
ICD-10 Finland
Palliative care
5.9
13.0
38
78
Z94.2
ICD-10 Finland
Lung transplant status
+∞
12.6
12
*
GDG10
NOMESCO Finland
Bilateral transplantation of lung
+∞
12.6
12
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.3
12.1
81
358
R28
ICPC
Limited function/disability (R)
32.4
11.8
15
5
127
Kela drug reimbursment
Transplant complication
+∞
10.5
10
*
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
34.8
10.5
13
*
N02AA01
ATC
morphine; systemic, rectal
21.5
10.0
14
7
J47
ICD-10 Finland
Bronchiectasis
21.5
10.0
14
7
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
3.0
9.7
72
329
R01AD12
ATC
fluticasone furoate; nasal
3.2
9.5
56
219
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.9
9.4
71
329
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.9
9.4
26
50
R03AK08
ATC
formoterol and beclometasone; inhalant
10.9
9.2
17
17
XG466
NOMESCO Finland
Sleep oxymetry
8.2
9.2
20
27
R03BB04
ATC
tiotropium bromide; inhalant
4.3
9.1
35
96
L04AX01
ATC
azathioprine; systemic
38.8
9.1
11
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
12.4
8.7
15
13
R02
ICPC
Shortness of breath/dyspnoea
3.9
8.5
36
108
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
94.2
8.5
9
*
R05
ICPC
Cough
3.1
8.4
53
215
KA1MN
NOMESCO Finland
Glomerular filtration rate (GFR) Isotope mesurement
+∞
8.4
8
*
J01FA06
ATC
roxithromycin; oral
2.6
8.4
82
433
J01FA10
ATC
azithromycin; systemic
2.5
8.2
103
625
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.8
7.9
26
61
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.1
7.3
19
34
A02BC02
ATC
pantoprazole; systemic
2.4
7.2
131
930
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.3
7.0
36
126
J01CA04
ATC
amoxicillin; systemic
2.6
7.0
146
1103
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
6.6
7.0
17
28
R03BA01
ATC
beclometasone; inhalant
3.5
6.9
32
104
XJC10
NOMESCO Finland
Oesophageal pH monitoring
23.5
6.7
9
*
R4110
NOMESCO Finland
Physiotherapy
2.4
6.6
66
345
R03AK07
ATC
formoterol and budesonide; inhalant
3.1
6.5
37
139
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.2
6.4
19
40
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
6.4
93
578
L04AD01
ATC
ciclosporin; systemic
+∞
6.3
6
*
XX4BW
NOMESCO Finland
NA
+∞
6.3
6
*
GX2C5
NOMESCO Finland
Short-lasting oximetry
+∞
6.3
6
*

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3023419) Bacteria identified in Sputum by Culture
59
18
46.67
95.31
2.9
1.7
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
111
136
17.74
94.67
1.5
1.2
titre
345.8
447.4
0.17
31
27
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
58
30
27.15
77.68
3.1
1.2
—
—
—
0
0
(3019060) Gas panel - Arterial blood
95
124
14.05
75.75
4.7
4.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
56
29
26.74
74.84
3.1
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
44
14
40.35
69.40
2.8
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
169
490
20.00
69.37
14.2
3.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
68
63
16.08
67.38
4.6
2.6
—
—
—
0
0
(4306422)
41
13
39.72
64.57
1.3
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
46
21
28.40
64.21
1.4
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
41
15
34.39
61.73
5.3
1.7
%
57.2
59.1
0.23
41
15
(3030905) Polymorphonuclear cells [#/volume] in Blood
41
15
34.39
61.73
5.0
1.6
e9/l
4.9
4.3
0.38
41
15
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
100
185
10.09
58.94
1.5
1.2
iu/ml
37.9
25.0
0.41
35
48
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
47
30
20.36
56.54
3.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
39
16
30.26
56.33
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
41
24
21.39
51.17
3.8
2.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
37
18
25.16
49.93
1.3
1.0
titre
108.0
—
—
5
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
37
18
25.16
49.93
1.2
1.1
u/ml
1.4
1.6
—
11
5
(3003396) Base excess in Arterial blood by calculation
100
227
8.03
47.46
11.0
7.5
mmol/l
1.9
1.0
1.77
88
176
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
39
24
20.09
47.42
2.9
1.3
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
32
13
29.28
46.07
2.7
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
35
19
22.26
44.96
1.1
1.0
u/ml
2.8
2.5
—
25
8
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
102
251
7.46
44.21
3.4
1.7
—
—
—
0
0
(4010399)
70
117
8.80
43.69
2.2
1.3
—
—
—
0
0
(3000492) Spirometry study
71
122
8.60
43.22
3.9
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
45
44
13.01
42.08
3.1
1.4
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
38
28
16.63
42.00
1.9
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
35
23
18.35
41.01
1.9
1.2
—
—
—
0
0
(4268621)
28
12
27.10
39.34
2.1
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
175
6.64
35.15
3.5
1.8
—
—
—
0
0
(44790047)
30
20
17.56
34.70
4.1
1.4
—
—
—
0
0
(44790048)
30
20
17.56
34.70
4.1
1.4
—
—
—
0
0
(44806118)
30
20
17.56
34.70
4.1
1.4
—
—
—
0
0
(44790049)
30
20
17.56
34.70
4.1
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
57
99
7.74
33.73
13.3
10.9
mmol/l
25.2
24.4
1.00
52
93
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
76
177
6.42
33.66
3.5
1.8
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
37
6
75.59
33.40
3.4
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
28
18
18.01
32.93
1.1
1.0
u/ml
357.7
233.3
—
23
9
(3021879) Hepatitis B virus core Ab [Presence] in Serum
48
71
8.65
32.65
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
28
19
17.05
32.02
3.5
3.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
28
19
17.05
32.02
1.1
1.0
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
43
58
9.24
31.49
1.3
1.1
u/ml
167.9
120.3
0.49
38
52
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
34
7
58.44
29.51
3.3
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
34
39
10.36
28.04
2.5
2.2
g/l
140.7
126.7
—
10
30
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
578
5.26
27.34
4.0
2.9
ng/l
961.0
1401.0
1.07
120
499
(3020779) Urea [Moles/volume] in Serum or Plasma
63
148
5.82
27.07
14.5
6.1
mmol/l
8.2
10.5
2.02
63
143
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
27
24
12.91
26.36
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
28
27
11.95
25.96
1.1
1.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
14
17.60
25.79
2.7
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
14
17.60
25.79
2.7
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
48
95
6.39
24.56
4.6
3.6
mmol/l
2.2
2.1
0.10
41
75
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
64
166
5.26
24.34
1.2
1.2
u/ml
6.6
2.5
0.53
15
58
(3023368) Bacteria identified in Blood by Culture
118
492
4.57
24.34
5.0
3.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
66
181
5.01
23.40
3.9
1.3
—
—
—
0
0
(3009343) pH of Capillary blood
48
100
6.05
23.22
4.9
3.5
ph
7.4
7.4
—
6
12
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
152
793
5.23
22.57
10.8
5.4
mmol/l
1.2
1.2
2.33
146
704
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
48
103
5.86
22.46
4.9
3.5
kpa
5.3
5.1
0.81
48
96
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
25
26
10.89
21.92
1.4
1.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
30
40
8.69
21.87
11.8
2.7
mmol/l
3.4
2.1
1.58
30
23
(3019832) Treponema pallidum Ab [Presence] in Serum
30
40
8.69
21.87
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
5
57.01
21.70
1.2
1.0
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
55
138
5.17
21.53
1.5
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
49
114
5.41
20.88
1.4
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
48
111
5.42
20.58
1.5
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
43
90
5.85
20.56
5.2
2.9
%
0.8
0.3
0.44
18
27
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
7
40.67
20.39
1.2
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
21
19
12.27
20.11
1.2
1.1
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
46
105
5.43
19.98
5.4
2.9
%
0.5
0.8
0.64
24
36
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
25
8
35.57
19.81
2.4
2.0
—
—
—
0
0
(3010421) pH of Blood
30
46
7.53
19.36
11.8
2.8
ph
7.4
7.4
0.27
30
37
(1616796) Gas panel - Central venous blood
28
40
8.01
19.20
8.3
2.7
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
24
8
33.95
18.84
1.2
1.0
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
80
297
3.88
18.37
2.5
1.5
mg/l
1.5
1.2
0.52
70
234
(3022313) Gas panel - Capillary blood
36
71
6.00
18.22
4.8
3.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
49
128
4.78
18.05
1.5
1.9
%
1.6
1.7
0.60
42
98
(40767503) Oxygen content in Capillary blood by calculation
26
39
7.54
17.04
3.2
2.1
%
16.7
16.1
—
9
20
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
20
5
44.23
16.68
4.0
3.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
43
108
4.83
16.53
18.9
10.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
23
9.58
16.18
1.3
1.0
—
—
—
0
0
(3020891) Body temperature
35
75
5.47
16.14
4.6
3.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
194
1585
+∞
16.01
33.8
13.5
mg/l
22.4
26.8
1.43
188
1233
(40760892) CBC W Ordered Manual Differential panel - Blood
73
278
3.61
15.78
11.5
3.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
19
5
41.80
15.70
2.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
40
100
4.78
15.41
4.8
3.0
%
0.1
0.2
0.69
20
32
(3018418) pH of Serum or Plasma
106
519
3.30
15.10
5.3
3.5
ph
7.4
7.4
0.44
33
85
(3022806) Fractional oxyhemoglobin in Capillary blood
18
20
9.82
14.90
2.4
1.4
%
87.9
89.6
0.35
18
20
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
144
853
3.67
14.83
12.0
6.1
mmol/l
1.2
1.2
0.45
120
713
(40758558) Short blood count panel - Blood
87
383
3.31
14.74
11.1
6.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
14
11.53
13.92
1.3
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
14
11.53
13.92
1.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
14
11.53
13.92
1.3
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
99
487
3.11
13.63
4.2
2.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
132
769
3.24
13.40
9.4
9.4
inr
1.3
1.3
0.27
56
208
(3025159) Blasts/100 leukocytes in Blood
36
94
4.47
13.05
5.2
3.0
%
0.1
0.0
0.48
18
29
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
37
102
4.25
12.48
1.8
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
17
8
23.12
12.24
1.4
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
121
694
2.98
12.20
21.2
8.1
e9/l
0.0
0.0
1.02
115
552
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
9
20.53
11.82
1.8
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
61
246
3.16
11.57
1.9
1.3
g/l
3.1
2.7
0.72
49
134
(3002582) Erythrocytes [#/volume] in Urine
104
562
2.83
11.53
4.4
3.2
e6/l
38.7
40.7
0.03
86
425
(40761536) Microorganisms panel - Urine sediment
42
136
3.67
11.27
3.1
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
97
514
2.77
11.05
4.1
3.0
e6/l
0.4
0.5
0.15
80
376
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
14
6
24.98
10.40
1.1
1.0
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
159
1111
3.39
10.40
6.1
3.8
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
107
619
2.62
9.91
5.7
3.6
e6/l
22.5
50.0
1.37
86
443
(3018677) aPTT in Platelet poor plasma by Coagulation assay
65
296
2.80
9.70
3.1
1.8
s
28.3
29.5
1.74
65
288
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
95
523
2.60
9.70
4.0
1.9
u/l
108.1
336.1
1.00
90
491
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
110
662
2.53
9.14
4.4
3.1
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
12
9.66
9.06
1.6
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
13
7
19.78
9.06
1.0
1.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
48
192
2.99
9.03
4.6
2.4
umol/l
10.3
12.9
0.38
48
174
(40768797) Stomach Pathology biopsy report
48
200
2.86
8.34
1.1
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
113
711
2.41
8.21
4.1
3.8
ng/l
41.1
45.4
0.09
95
550
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
10
11
9.53
8.15
1.0
1.0
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
14
8.27
8.07
1.3
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
32
109
3.32
7.83
1.8
1.6
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
62
306
2.51
7.64
3.9
3.1
e6/l
0.5
0.9
0.71
37
177
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
70
367
2.42
7.56
4.9
3.6
ng/l
1292.7
419.4
1.02
60
315
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
11
7
16.55
7.32
1.0
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
16
34
5.04
7.31
2.5
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
10
5
20.96
7.21
1.3
1.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
62
315
2.42
7.12
3.6
2.8
e6/l
0.4
0.8
1.08
39
182
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
43
186
2.69
6.88
5.6
3.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
11
9
12.86
6.67
2.6
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
21
60
3.80
6.65
2.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
60
3.80
6.65
1.4
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
51
4.02
6.54
6.5
2.3
u/ml
0.3
0.4
0.81
11
26
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
93
579
2.16
6.45
2.7
2.1
nmol/l
71.5
76.3
0.99
83
484
(3026493) Urate [Moles/volume] in Serum or Plasma
73
413
2.23
6.43
8.0
2.6
umol/l
8555.3
13385.0
0.23
66
341
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
107
707
2.14
6.33
2.8
2.1
—
—
—
0
0
(4062490)
9
5
18.77
6.32
1.1
1.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
31
118
2.94
6.26
2.0
1.7
ug/g
203.2
146.1
0.50
26
93
(3042936) Bacteria identified in Isolate by Culture
51
252
2.39
6.13
4.3
1.8
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
24
5.26
5.82
1.3
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
35
148
2.67
5.81
2.1
2.3
e9/l
76.5
69.9
0.32
22
114
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
25
5.05
5.57
1.7
2.0
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
163
1309
2.53
5.52
38.2
18.2
%
14.2
13.7
4.02
163
1276
(3003694) ABO and Rh group [Type] in Blood
71
421
2.08
5.39
1.9
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
9
8
11.72
5.34
3.3
2.0
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
0
+∞
5.23
1.4
0.0
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
5
0
+∞
5.23
1.6
0.0
%
9.6
—
—
5
0
(3026782) Osmolality of Urine
62
355
2.10
5.13
3.4
2.8
mosm/kgh2o
567.8
590.8
0.40
57
295
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
11
23
5.01
5.08
1.8
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
23
5.01
5.08
1.4
1.5
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
50
265
2.19
5.02
2.1
2.4
umol/l
12.6
13.3
0.28
50
238
(3000991) Gas panel - Venous blood
35
159
2.47
5.00
20.7
8.5
—
—
—
0
0
(3044889) 12 lead EKG panel
154
1227
2.24
4.98
6.9
4.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
109
769
1.95
4.94
4.4
3.4
estimate
0.0
0.0
0.00
37
140
(3026008) Bacteria identified in Urine by Culture
78
497
1.95
4.73
2.6
2.8
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
109
781
1.90
4.60
4.5
3.4
estimate
0.0
0.0
0.00
36
126
(3015377) Calcium [Moles/volume] in Serum or Plasma
85
562
1.91
4.59
5.6
3.5
mmol/l
2.3
2.3
0.52
78
484
(3021601) Nitrite [Presence] in Urine by Test strip
108
774
1.89
4.53
6.2
4.6
estimate
0.0
0.0
0.00
38
138
(3015235) Bicarbonate [Moles/volume] in Capillary blood
16
50
3.40
4.44
4.9
2.6
mmol/l
26.1
25.4
0.26
16
43
(3021901) Oxygen saturation in Capillary blood
14
40
3.69
4.42
4.6
2.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
44
233
2.15
4.39
2.1
2.4
%
23.9
23.8
0.00
36
197
(3011397) Hemoglobin [Presence] in Urine by Test strip
59
352
1.97
4.26
4.4
3.3
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
69
439
1.89
4.10
4.2
3.6
estimate
0.0
0.0
0.00
35
129
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
10
8.28
4.10
1.0
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
59
3.06
4.01
2.2
1.4
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
60
370
1.90
3.89
2.0
1.8
pmol/l
469.6
19192368.1
0.50
48
297
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
39
3.50
3.83
1.5
1.5
ug/g
230.6
280.1
—
8
24
(1175426) CD3 cells/100 lymphocytes in Blood
6
5
12.32
3.79
1.5
2.4
%
69.3
65.2
—
6
5
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
5
12.32
3.79
5.3
1.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
98
2.53
3.74
1.3
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
12
6.90
3.71
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
12
6.90
3.71
1.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
12
6.90
3.71
1.0
1.5
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
13
6.36
3.54
1.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
13
6.36
3.54
1.0
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
7
10
7.21
3.39
1.3
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
11
34
3.37
3.11
1.9
1.6
—
—
—
0
0
(3013512) EKG study
77
548
1.67
2.95
4.1
4.0
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
12
41
3.05
2.91
1.9
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
6
8.51
2.76
1.6
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
174
1556
2.15
2.74
30.3
14.2
ml/min/173m2
77.2
74.6
1.18
151
1268
(3009542) Hematocrit [Volume Fraction] of Blood
160
1392
1.85
2.73
37.0
16.3
%
39.5
39.6
0.03
103
868
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
7
15
4.80
2.62
1.1
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
82
608
1.60
2.60
3.2
3.3
mg/l
51.0
241.8
0.87
60
410
(3009508) Creatinine [Moles/volume] in Urine
82
613
1.58
2.49
3.2
3.2
mmol/l
7.2
7.8
0.61
66
500
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
27
3.44
2.42
1.0
1.1
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
84
647
1.53
2.17
4.0
4.0
mg/mmol
6.8
10.0
0.51
55
420
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
49
2.54
2.15
1.6
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
37
2.80
2.14
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
37
2.80
2.14
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
37
2.80
2.14
1.3
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
56
0.00
2.10
0.0
4.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
6
15
4.09
2.05
1.2
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
11
44
2.59
2.05
1.4
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
180
1664
2.13
2.04
5.4
5.8
mmol/l
2.6
2.6
0.08
159
1494
(3019225) pH of Specimen
27
158
1.82
2.02
3.2
3.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
79
609
1.50
1.99
4.3
3.6
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
11
45
2.53
1.97
3.9
2.7
umol/l
35.7
35.7
0.00
11
36
(3001122) Ferritin [Mass/volume] in Serum or Plasma
79
611
1.49
1.95
2.4
2.4
ug/l
234.2
173.3
0.99
74
551
(3041096) Erythrocytes [Presence] in Urine by Automated
58
420
1.54
1.95
3.7
3.3
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
6
16
3.83
1.95
2.2
1.3
—
—
—
0
0
(3012544) pH of Venous blood
29
177
1.75
1.90
3.8
3.3
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
11
46
2.47
1.89
1.0
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
162
1461
1.66
1.86
4.6
4.3
mu/l
2.0
2.1
0.57
143
1266
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
17
3.61
1.85
1.5
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
177
1638
1.92
1.82
5.3
5.2
mmol/l
6.0
6.2
1.32
154
1455
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
133
1156
1.48
1.74
3.8
3.5
pmol/l
15.0
15.0
0.12
121
988
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
5
13
3.92
1.72
1.0
1.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
19
3.22
1.67
1.5
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
19
3.22
1.67
1.5
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
95
784
1.41
1.59
5.8
3.9
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
43
0.00
1.54
0.0
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
173
1608
1.70
1.50
4.8
5.1
mmol/l
1.4
1.4
0.18
150
1434
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
174
1621
1.71
1.47
4.8
5.1
mmol/l
4.4
4.4
0.16
151
1474
(3021960) Folate [Moles/volume] in Serum or Plasma
60
463
1.43
1.44
1.8
1.4
nmol/l
19.8
21.4
0.35
55
382
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
168
1.63
1.40
3.8
3.3
kpa
5.9
5.6
0.68
26
163
(3002032) Base excess in Venous blood by calculation
26
168
1.63
1.40
3.8
3.3
mmol/l
1.6
1.5
0.02
21
131
(3012441) Differential panel - Pleural fluid
6
23
2.66
1.38
1.7
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
17
2.99
1.36
3.4
3.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
168
1560
1.57
1.34
4.3
4.5
mmol/l
1.3
1.3
0.26
147
1382
(3022145) Colonoscopy Study observation
28
187
1.58
1.33
1.1
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
5
18
2.82
1.29
1.0
1.6
%
9.7
11.0
—
5
18
(40760888) Immunoglobulin light chains.free panel - Serum
8
36
2.27
1.26
2.1
3.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
25
165
1.59
1.25
3.0
2.0
nmol/l
12.2
13.2
0.30
25
144
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
19
2.67
1.22
1.0
1.0
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
26
2.35
1.19
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
95
1.75
1.18
2.1
2.5
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
39
2.10
1.16
2.0
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
75
623
1.33
1.12
2.4
2.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
31
2.30
1.11
1.1
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
5
21
2.42
1.09
1.2
1.3
—
—
—
0
0
(4035726)
21
139
1.57
1.05
1.3
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
22
2.31
1.04
2.4
1.4
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
168
1584
1.45
0.97
6.4
6.8
mmol/mol
41.3
41.1
0.09
150
1452
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
38
290
1.39
0.96
1.2
1.2
u/ml
1.3
1.6
—
8
74
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
24
168
1.49
0.95
2.3
1.5
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
18
119
1.57
0.92
2.1
2.3
nmol/l
331.8
390.4
0.73
18
113
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
87
1.66
0.90
1.1
1.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
6
29
2.10
0.90
1.7
1.5
g/l
32.6
31.8
—
6
23
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
6
32
1.90
0.82
1.5
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
45
363
1.31
0.81
2.2
1.7
nmol/l
988.8
1152.9
0.72
35
272
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
28
0.00
0.76
0.0
3.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
28
0.00
0.76
0.0
3.1
—
4.1
—
0
28
(3035285) Chloride [Moles/volume] in Venous blood
0
28
0.00
0.76
0.0
3.1
—
105.1
—
0
28
(3007853) Bacteria identified in Skin by Aerobe culture
24
177
1.41
0.75
1.8
1.5
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
5
26
1.95
0.71
1.4
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
95
1.51
0.66
1.1
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
112
1.47
0.66
1.6
2.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
148
1.39
0.62
1.3
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
4.6
—
56.2
—
0
21
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
36
1.69
0.57
1.7
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
9
59
1.55
0.56
2.2
1.9
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
29
233
1.29
0.55
4.0
5.1
%
33.4
31.0
0.58
20
137
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
62
1.47
0.54
1.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
62
1.47
0.54
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
43
502
0.82
0.53
2.3
3.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
26
207
1.30
0.53
2.9
3.5
u/l
299.2
245.6
1.28
26
197
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
109
1010
1.18
0.51
3.8
5.5
ug/l
1.6
2.7
2.42
95
895
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
101
1.42
0.51
2.2
2.3
%
1.4
1.2
0.39
14
101
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
47
404
1.22
0.51
2.8
2.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
47
1.51
0.48
1.6
2.6
—
—
—
0
0
(1002224) Polysomnography panel
7
51
1.39
0.44
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
52
585
0.85
0.43
2.4
3.2
ug/l
0.6
0.8
1.90
38
418
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.5
—
4.6
—
0
15
(3020876) Protein [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.1
—
149.1
—
0
15
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
16
0.00
0.41
0.0
2.5
—
3.6
—
0
16
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
16
0.00
0.41
0.0
1.1
—
40.0
—
0
9
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
436.7
—
0
10
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.0
—
286.0
—
0
9
(4281824)
0
17
0.00
0.41
0.0
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
34
1.48
0.40
1.2
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
5
35
1.44
0.39
3.8
3.5
nmol/l
0.9
0.8
—
5
29
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
6
42
1.44
0.36
2.7
1.4
mg/l
58.4
2.8
—
6
31
(3030981) Hyaline casts [#/volume] in Urine by Automated count
13
101
1.31
0.32
3.3
3.3
e6/l
0.1
0.2
0.53
13
101
(3019230) Fractional oxyhemoglobin in Venous blood
6
47
1.29
0.32
1.0
1.5
%
56.5
58.8
—
6
47
(3049717) Cytology report of Urine Cyto stain
7
98
0.70
0.31
4.3
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
7
54
1.31
0.30
2.1
2.6
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
71
0.70
0.26
1.0
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
80
755
1.10
0.24
2.2
2.0
pmol/l
95.2
91.3
0.20
44
368
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
11
0.00
0.21
0.0
1.2
—
8.1
—
0
11
(3032773) Endomysium IgG Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
38
352
1.10
0.16
5.6
3.8
kg/l
1.0
1.0
—
7
51
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7
87
0.80
0.15
1.0
1.2
—
61.1
—
0
6
(3044640) Blood type and Crossmatch panel - Blood
57
541
1.08
0.14
2.8
2.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
12
103
1.18
0.14
1.5
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
55
1.09
0.09
1.7
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
19
203
0.93
0.06
1.4
1.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
21
199
1.06
0.05
1.6
5.5
ug/l
14.1
42.9
0.56
16
169
(3022621) pH of Urine by Test strip
12
111
1.09
0.04
6.9
2.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
821
0.98
0.03
3.1
4.7
%
21.6
21.5
0.02
30
421
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
24
234
1.03
0.00
6.5
7.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
14
137
1.02
0.00
3.3
3.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
49
493
0.99
0.00
1.8
1.7
mmol/l
1.7
1.3
1.28
38
394
(3024354) Oxygen [Partial pressure] in Venous blood
14
145
0.96
0.00
2.1
2.7
kpa
4.7
4.5
0.19
14
139
(4034850)
5
58
0.86
0.00
7.0
11.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
1447.8
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
5
0.00
0.00
0.0
1.2
—
5.3
—
0
5
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
225.0
—
0
8
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.7
—
68.8
—
0
6
(3025130) Human papilloma virus identified in Specimen
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4027681)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
9
0.00
0.00
0.0
2.7
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
5.8
—
0
7
(40765096) Chromosome analysis panel by Banding
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4211845)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.0
—
249.3
—
0
9
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.6
—
46.6
—
0
7
(1001926) Buprenorphine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.8
—
1.0
—
0
6
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
6
0.00
0.00
0.0
5.2
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
0
8
0.00
0.00
0.0
3.6
—
68.9
—
0
8

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ILD_NINTENDANIB – ILD medications: nintedanib

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).